Pathological reporting of cystectomy lymph nodes: a retrospective analysis of experience in Paris.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 15 12 2020
accepted: 03 02 2021
pubmed: 21 3 2021
medline: 19 2 2022
entrez: 20 3 2021
Statut: ppublish

Résumé

Pathological evaluation of pelvic lymph node (LN) dissection (PLND) is important for management of cystectomy patients. However, challenges such as unclear interobserver variability of LN counting remain. Here, we assess interobserver variability of LN measures and their clinical utility, with a focus on variant histology. We retrieved radical cystectomy cases with PLND between 2010 and 2016 and reevaluated pathological parameters; number of total and metastatic LN, LN density (LND), length of metastatic LN and metastases, extranodal extension (ENE). We report 96 patients: median age of 71a, 34 cases pN+, 36 cases with any extent of variant histology, median follow-up 10 months. Perivesical LN were only rarely identified, but frequently metastatic (4/9). Variant histology (34 cases) frequently exhibited LN metastasis (53% of pN+ cases). Interobserver variance was poor for total LN (kappa = 0.167), excellent for positive LN (0.85) and pN staging (0.96), and mediocre for LND (0.53). ROC analysis suggests that both LND and the sum of LN metastasis length may predict outcome (AUC 0.83 and 0.75, respectively). Our study confirms the notion of LND as a prognostic measure, but cautions due to strong interobserver variance of LN counts. The sum length of LN metastases could be a measure that is independent of LN counts. We find that microscopically identified perivesical LN merit particular attention. In summary, our study highlights current challenges in pathological reporting of PLND, confirms previous observations and forms a basis for further studies.

Identifiants

pubmed: 33743060
doi: 10.1007/s00345-021-03630-8
pii: 10.1007/s00345-021-03630-8
pmc: PMC8571145
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4029-4035

Informations de copyright

© 2021. The Author(s).

Références

Eur Urol. 2019 Nov;76(5):639-657
pubmed: 31443960
Prog Urol. 2012 Oct;22(12):705-10
pubmed: 22999117
J Urol. 2003 Jul;170(1):35-41
pubmed: 12796639
Eur Urol. 2011 Nov;60(5):946-52
pubmed: 21802833
Am J Clin Pathol. 2010 Jul;134(1):42-9
pubmed: 20551265
Ann Pathol. 2019 Apr;39(2):158-166
pubmed: 30711335
Nat Rev Urol. 2017 Nov;14(11):651-668
pubmed: 28895563
Virchows Arch. 2009 Nov;455(5):449-53
pubmed: 19841937
Virchows Arch. 2020 Apr;476(4):521-534
pubmed: 31915958
J Urol. 2012 Feb;187(2):446-50
pubmed: 22177147
Eur Urol. 2017 Mar;71(3):462-475
pubmed: 27375033
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Eur Urol. 2014 Dec;66(6):987-90
pubmed: 25150172
Histopathology. 2019 May;74(6):844-852
pubmed: 30604878
Urology. 2010 Feb;75(2):382-6
pubmed: 19819539
Eur Urol. 2014 Dec;66(6):1065-77
pubmed: 25074764
Eur Urol. 2021 Jan;79(1):82-104
pubmed: 32360052
Urol Oncol. 2020 Oct;38(10):796.e7-796.e14
pubmed: 32446641
Eur Urol. 2013 Apr;63(4):739-44
pubmed: 23079053
BJU Int. 2016 Feb;117(2):253-9
pubmed: 25307941
J Clin Pathol. 2016 Dec;69(12):1039-1045
pubmed: 27555432
Eur Urol. 2013 Nov;64(5):837-45
pubmed: 22877503

Auteurs

André Oszwald (A)

Department of Pathology, Medical University of Vienna, Vienna, Austria.

Gabriel Wasinger (G)

Department of Pathology, Medical University of Vienna, Vienna, Austria.

Laura Larnaudie (L)

Department of Pathology, GRC n°5 Predictive Onco-Urology, AP-HP, Tenon Hospital, Sorbonne University, 75020, Paris, France.

Justine Varinot (J)

Department of Pathology, GRC n°5 Predictive Onco-Urology, AP-HP, Tenon Hospital, Sorbonne University, 75020, Paris, France.

Philippe Sebe (P)

Department of Urology, La Croix Saint-Simon, Paris, France.

Olivier Cussenot (O)

CeRePP, 75020, Paris, France.
Department of Urology, GRC n°5 Predictive Onco-Urology, AP-HP, Tenon Hospital, Sorbonne University, 75020, Paris, France.

Eva Compérat (E)

Department of Pathology, Medical University of Vienna, Vienna, Austria. evacomperat@gmail.com.
Department of Pathology, GRC n°5 Predictive Onco-Urology, AP-HP, Tenon Hospital, Sorbonne University, 75020, Paris, France. evacomperat@gmail.com.
CeRePP, 75020, Paris, France. evacomperat@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH